Although this sample size proved to be enough to show that the pneumonia and COPD-E compromise interpretation of serum proGRP results, the size is still too low to accurately assess diagnostic properties of proGRP in differentiation of major NSCLC subtypes from pneumonia and COPD. This evidence concerns the gene GRP and non-small cell lung carcinoma.